Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study

IF 1.1 Q4 HEMATOLOGY Hematology Reports Pub Date : 2023-12-04 DOI:10.3390/hematolrep15040069
A. Gidaro, Alessandro Palmerio Delitala, Roberto Manetti, Sonia Caccia, M. Soloski, Giorgio Lambertenghi Deliliers, D. Castro, Mattia Donadoni, Arianna Bartoli, Giuseppe Sanna, Luigi Bergamaschini, Roberto Castelli
{"title":"Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study","authors":"A. Gidaro, Alessandro Palmerio Delitala, Roberto Manetti, Sonia Caccia, M. Soloski, Giorgio Lambertenghi Deliliers, D. Castro, Mattia Donadoni, Arianna Bartoli, Giuseppe Sanna, Luigi Bergamaschini, Roberto Castelli","doi":"10.3390/hematolrep15040069","DOIUrl":null,"url":null,"abstract":"Background: Platelet “Microvesicles” (MVs) are studied for their role in blood coagulation and inflammation. The study aimed to establish if MVs are related to age, plasma levels of inflammation, coagulation, and fibrinolysis markers in healthy individuals. Methods: We prospectively enrolled volunteers aged over 18 years. MVs, plasma levels of C-reactive protein (CRP), Interleukin 6 (IL-6), Interleukin 10 (IL-10), Interleukin 17 (IL-17), and transforming growth factor β (TGF-β), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), von Willebrand factor (VWF), homocysteine, factor VII (FVII), thrombin activatable fibrinolysis inhibitor (TAFI), and Protein S were tested. Results: A total of 246 individuals (median age 65 years (“IQR”54–72)) were evaluated. Both univariate analysis and logistic regression models showed that MVs positively correlate with age, CRP, IL-6, IL-10, IL-17, TGF-β, fibrinogen, PAI-1, VWF, FVII, and homocysteine, while inversely correlating with TAFI and Protein S. The ROC curve analysis performed to identify a cut off for MV values (700 kMP) showed a good accuracy with over-range cytokines fibrinolysis factor and coagulation markers. Conclusions: To the best of our knowledge, this study is the first to correlate MVs with an entire panel of cardiovascular risk factors in healthy individuals. A future possible role of MVs in screening exams is suggested.","PeriodicalId":12829,"journal":{"name":"Hematology Reports","volume":"44 23","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/hematolrep15040069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Platelet “Microvesicles” (MVs) are studied for their role in blood coagulation and inflammation. The study aimed to establish if MVs are related to age, plasma levels of inflammation, coagulation, and fibrinolysis markers in healthy individuals. Methods: We prospectively enrolled volunteers aged over 18 years. MVs, plasma levels of C-reactive protein (CRP), Interleukin 6 (IL-6), Interleukin 10 (IL-10), Interleukin 17 (IL-17), and transforming growth factor β (TGF-β), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), von Willebrand factor (VWF), homocysteine, factor VII (FVII), thrombin activatable fibrinolysis inhibitor (TAFI), and Protein S were tested. Results: A total of 246 individuals (median age 65 years (“IQR”54–72)) were evaluated. Both univariate analysis and logistic regression models showed that MVs positively correlate with age, CRP, IL-6, IL-10, IL-17, TGF-β, fibrinogen, PAI-1, VWF, FVII, and homocysteine, while inversely correlating with TAFI and Protein S. The ROC curve analysis performed to identify a cut off for MV values (700 kMP) showed a good accuracy with over-range cytokines fibrinolysis factor and coagulation markers. Conclusions: To the best of our knowledge, this study is the first to correlate MVs with an entire panel of cardiovascular risk factors in healthy individuals. A future possible role of MVs in screening exams is suggested.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血小板微泡、炎症和凝血标志物:一项试点研究
背景:研究血小板“微泡”(MVs)在凝血和炎症中的作用。该研究旨在确定健康人的MVs是否与年龄、血浆炎症水平、凝血和纤溶标志物有关。方法:我们前瞻性地招募年龄在18岁以上的志愿者。检测MVs、血浆c反应蛋白(CRP)、白细胞介素6 (IL-6)、白细胞介素10 (IL-10)、白细胞介素17 (IL-17)、转化生长因子β (TGF-β)、纤维蛋白原、纤溶酶原激活物抑制剂-1 (PAI-1)、血管性血友病因子(VWF)、同型半胱氨酸、因子VII (FVII)、凝血酶活化纤维蛋白溶解抑制剂(TAFI)、蛋白S水平。结果:共评估246例患者(中位年龄65岁(“IQR”54-72))。单因素分析和logistic回归模型均显示,MV与年龄、CRP、IL-6、IL-10、IL-17、TGF-β、纤维蛋白原、PAI-1、VWF、FVII和同型半胱氨酸呈正相关,而与TAFI和Protein s呈负相关。通过ROC曲线分析确定MV值的截断值(700 kMP),发现MV值与超范围细胞因子、纤溶因子和凝血标志物具有良好的准确性。结论:据我们所知,这项研究是第一个将mv与健康个体的心血管危险因素联系起来的研究。提出了未来mv在筛查检查中的可能作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hematology Reports
Hematology Reports HEMATOLOGY-
CiteScore
0.90
自引率
0.00%
发文量
47
审稿时长
10 weeks
期刊最新文献
Awareness and Attitude of the General Population Towards Inherited Hemoglobinopathies in the Premarital Screening Program in the Northern Region of Saudi Arabia. Solid Tumors, Liquid Challenges: The Impact of Coagulation Disorders. Bosutinib-Induced Pleural Effusion-Class Effect and Cross-Intolerance to All Tyrosine Kinase Inhibitors. Risk Factors for Impaired Glucose Metabolism in Transfusion-Dependent Patients with β-Thalassemia: A Single-Center Retrospective Observational Study. The Role of Ferritin and Folate in Determining Stem Cell Collection for Autologous Stem Cell Transplant in Multiple Myeloma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1